This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. John Zuris, PhD
Director of Delivery and Editing Technologies at Editas Medicine
Speaker

Agenda Sessions

  • Workshop AM3: Introduction to Genome Editing and Delivery

    9:00am
  • In Vivo Editing of HBG1/2 Promoters Leads to Fetal Hemoglobin Reactivation in Humanized Mouse Model

    10:45am
  • Chairman’s Remarks: Genome Editing Preclinical and Clinical Updates: Part 2

    1:55pm